HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of contact versus non-contact diode laser cyclophotocoagulation for refractory glaucomas using similar energy settings.

AbstractPURPOSE:
To compare the efficacy of contact and non-contact techniques of diode transscleral cyclophotocoagulation (TSCPC) in patients with refractory glaucoma in a prospective randomized manner.
METHODS:
Sixty eyes with refractory glaucoma were randomly treated with either the contact or non-contact technique of diode TSCPC and followed up for a minimum of 12 months. A standard protocol of 1500 mW for 2 s per spot, with 40 spots over the entire 360 degrees circumference was followed for all eyes in both groups.
RESULTS:
The reduction of mean baseline intraocular pressure (IOP) from 44.5 +/- 7.4 mmHg to 14.8 +/- 1.8 mmHg with the contact mode was not significantly different from that in the non-contact mode of 41.9 +/- 8.8 mmHg reduced to 14.5 +/- 1.5 mmHg (P = 0.34). The probability of IOP survival (<22 mmHg) at 1 year using the Kaplan-Meier plot was better using the contact mode, although the results did not achieve statistical significance. However, the average repeat treatments per eye with the non-contact mode (1.6 +/- 0.7) was significantly higher than with the contact method (1.2 +/- 0.6; P < 0.05).
CONCLUSION:
Using an energy setting of 3 J per spot, both the contact and non-contact methods of laser delivery were found to be equally effective in lowering IOP in eyes with refractory glaucoma.
AuthorsHarish C Agarwal, Viney Gupta, Ramanjit Sihota
JournalClinical & experimental ophthalmology (Clin Exp Ophthalmol) Vol. 32 Issue 1 Pg. 33-8 (Feb 2004) ISSN: 1442-6404 [Print] Australia
PMID14746588 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Topics
  • Adult
  • Ciliary Body (surgery)
  • Female
  • Glaucoma (surgery)
  • Humans
  • Intraocular Pressure
  • Intraoperative Complications
  • Laser Coagulation (methods)
  • Male
  • Postoperative Complications
  • Prospective Studies
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: